Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000 |
Par Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | $154,000,000 |
Perrigo Company | Perrigo | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | $750,000 |
Pfizer | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2003 | $6,000,000 |
Pfizer | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | $35,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $21,084,700 |
Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,621,154 |
Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | $60,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $42,900,000 |
Pfizer, Inc. | Pfizer | pharmaceuticals | kickbacks and bribery | 2009 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170 |
Purdue Frederick Company Inc. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2007 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $160,000,000 |
Purdue Pharma | Purdue Pharma | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | $19,500,000 |
Ranbaxy | Sun Pharmaceuticals | pharmaceuticals | drug or medical equipment safety violation | 2013 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $266,729,715 |
Salix Pharmaceuticals Inc. | Bausch Health | pharmaceuticals | kickbacks and bribery | 2016 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,470,000 |
Sanofi US Services, Inc. | Sanofi | pharmaceuticals | kickbacks and bribery | 2013 | $617,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | kickbacks and bribery | 2004 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $292,969,482 |
Schering-Plough Corporation | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $91,602,000 |
Schwarz Pharma Inc. | UCB | pharmaceuticals | False Claims Act and related | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,756,164 |
Serono Inc. | Merck KGaA (EMD) | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $262,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2017 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,104,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,786,034 |
SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | $10,000,000 |
Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | $17,551,650 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | $169,000,000 |
UCB Inc. | UCB | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,893,322 |
UCB Pharma, Inc. | UCB | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | $2,275,454 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | investor protection violation | 2017 | $145,000,000 |
Warner Chilcott Holdings | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | $5,500,000 |
Warner Chilcott PLC | AbbVie | pharmaceuticals | False Claims Act and related | 2015 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,600,000 |
Warner-Lambert | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2004 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | $70,000,000 |
Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180 |
Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | $116,860,000 |
Avanir Pharmaceuticals | Otsuka Pharmaceutical | pharmaceuticals | False Claims Act and related | 2019 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,000,000 |
Mallinckrodt | Mallinckrodt | pharmaceuticals | Controlled Substances Act violation | 2020 | $1,600,000,000 |
Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | kickbacks and bribery | 2020 | $103,000,000 |
Pacira Pharmaceuticals, Inc. | Pacira BioSciences | pharmaceuticals | kickbacks and bribery | 2020 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Indivior plc | Indivior PLC | pharmaceuticals | off-label or unapproved promotion of medical products | 2021 | $300,000,000 |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2021 | $75,000,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2021 | $5,000,000,000 |
Endo International plc | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | $450,000,000 |
Allergan | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | $2,370,000,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | $4,250,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | $8,200,000 |
Allergan | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | $4,800,000 |
Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | $102,500,000 |
Hikma Pharmaceuticals | Hikma Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | $150,000,000 |
El Paso Corporation | Kinder Morgan | pipelines | price-fixing or anti-competitive practices | 2003 | $1,450,000,000 |
Sunoco | Energy Transfer | pipelines | environmental violation | 2005 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,900,000 |
Akzo Nobel Inc. | Carlyle Group | private equity (including portfolio companies) | price-fixing or anti-competitive practices | 2009 | $2,275,454 |
America Online | Apollo Global Management | private equity (including portfolio companies) | consumer protection violation | 2007 | $3,000,000 |
Anchor Glass Container Corporation | CVC Capital Partners | private equity (including portfolio companies) | air pollution violation | 2018 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $550,000 |
Aviva Life & Annuity Company | Apollo Global Management | private equity (including portfolio companies) | insurance violation | 2013 | $4,000,000 |
Classmates Inc. | H.I.G. Capital | private equity (including portfolio companies) | consumer protection violation | 2015 | $8,177,600 |
LifeScan, Inc. | Platinum Equity | private equity (including portfolio companies) | drug or medical equipment safety violation | 2003 | $30,600,000 |
MoneyGram Payment Systems | Madison Dearborn Partners | private equity (including portfolio companies) | consumer protection violation | 2016 | $13,000,000 |
MoneyGram Payment Systems, Inc. | Madison Dearborn Partners | private equity (including portfolio companies) | consumer protection violation | 2008 | $1,100,000 |
Neiman Marcus Group LLC | Ares Management | private equity (including portfolio companies) | privacy violation | 2019 | $1,500,000 |
PharMerica Corp. | KKR & Co. | private equity (including portfolio companies) | kickbacks and bribery | 2015 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,500,000 |
Simon and Schuster Inc. | KKR & Co. | private equity (including portfolio companies) | price-fixing or anti-competitive practices | 2013 | $20,641,666 |
Apria Healthcare Group, Inc. and Apria Healthcare LLC | Blackstone | private equity (including portfolio companies) | False Claims Act and related | 2021 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
PharMerica Inc. | KKR & Co. | private equity (including portfolio companies) | kickbacks and bribery | 2022 | $4,900,000 |
7-Eleven, Inc. | Seven & I Holdings | retailing | tobacco litigation | 2005 | $375,000 |
Caremark | CVS Health | retailing | kickbacks and bribery | 2008 | $41,000,000 |
Caremark LLC | CVS Health | retailing | False Claims Act and related | 2013 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,940,000 |
Circle K Stores, Inc. | Couche-Tard | retailing | tobacco litigation | 2011 | $225,000 |
CVS Caremark Corp. | CVS Health | retailing | False Claims Act and related | 2008 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $15,600,000 |
CVS Corporation | CVS Health | retailing | False Claims Act and related | 2001 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,000,000 |
CVS Pharmacies, Inc. | CVS Health | retailing | consumer protection violation | 2003 | $1,100,000 |
CVS Pharmacy | CVS Health | retailing | tobacco litigation | 2006 | $250,000 |
CVS Pharmacy, Inc. | CVS Health | retailing | False Claims Act and related | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,506,384 |
Eckerd Corporation | Rite Aid | retailing | False Claims Act and related | 2002 | $3,133,248 |
Kmart Corporation | Sears | retailing | False Claims Act and related | 2013 | $2,550,000 |
Kroger Company | Kroger | retailing | tobacco litigation | 2007 | $325,000 |
Murphy Oil USA Inc. | Murphy USA | retailing | air pollution violation | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $624,999 |
Omnicare | CVS Health | retailing | kickbacks and bribery | 2014 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,190,000 |
Omnicare Inc. | CVS Health | retailing | False Claims Act and related | 2009 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $38,100,000 |
Omnicare Inc. | CVS Health | retailing | False Claims Act and related | 2017 | $23,000,000 |
Omnicare Inc. | CVS Health | retailing | False Claims Act and related | 2010 | $21,050,000 |
Omnicare Inc. | CVS Health | retailing | False Claims Act and related | 2006 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $19,858,782 |
Omnicare Inc. | CVS Health | retailing | False Claims Act and related | 2014 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $8,240,000 |
Omnicare Inc. | CVS Health | retailing | kickbacks and bribery | 2016 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $28,125,000 |
Rite Aid Corporation | Rite Aid | retailing | False Claims Act and related | 2004 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,400,000 |
Rite Aid Corporation | Rite Aid | retailing | tobacco litigation | 2004 | $250,000 |
Target Corporation | Target | retailing | privacy violation | 2017 | $18,500,000 |
TJX | TJX | retailing | privacy violation | 2009 | $9,750,000 |
Walgreen Co. | Walgreens Boots Alliance | retailing | False Claims Act and related | 2008 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $16,400,000 |
Walgreen Co. | Walgreens Boots Alliance | retailing | False Claims Act and related | 2017 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,790,000 |
Walgreens | Walgreens Boots Alliance | retailing | False Claims Act and related | 2008 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,900,000 |
Walgreens | Walgreens Boots Alliance | retailing | False Claims Act and related | 2012 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $600,000 |
Walgreens | Walgreens Boots Alliance | retailing | tobacco litigation | 2002 | $320,000 |
Walgreens Boots Alliance | Walgreens Boots Alliance | retailing | False Claims Act and related | 2019 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $69,200,000 |
Wal-Mart Stores, Inc. | Walmart | retailing | False Claims Act and related | 2004 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,866,904 |
Zappos.com Inc. | Amazon.com | retailing | privacy violation | 2015 | $106,000 |
Home Depot | Home Depot | retailing | privacy violation | 2020 | $17,500,000 |
Wawa, Inc. | Wawa Inc. | retailing | privacy violation | 2022 | $8,000,000 |
Walmart Stores | Walmart | retailing | off-label or unapproved promotion of medical products | 2022 | $3,100,000,000 |
CarMax Auto Superstores Inc. | CarMax | retailing | consumer protection violation | 2022 | $1,000,000 |